Q&A: Expert discusses the ‘boundless potential’ of CAR T cell therapy

For most of modern medicine, cancer drugs have been developed the same way: by designing molecules to treat diseased cells. With the advent of immunotherapy, that changed. For the first time, scientists engineered patients’ own immune systems to recognize and attack diseased cells.

Leave A Comment

Your email address will not be published. Required fields are marked *